Business Information
The group's principal activities are to develop, manufacture and market medical devices for use in soft-tissue surgery. The products are based on its patented coblation technology that allows surgeons to operate with a high level of precision and accuracy, limiting damage to surrounding tissue and thereby reducing pain and speeding recovery for the patient. This technology is applicable to a broad range of soft-tissue surgical markets that includes sports medicine, spinal surgery, neurosurgery, cosmetic surgery, ear, nose and throat (ent) surgery, gynecology, urology, general surgery and various cardiology applications. The products are marketed in the United States, Europe, Australia, New Zealand, China, Korea, Japan, Taiwan, Canada, Mexico, the Caribbean, north Africa, the Middle East, and Central America. On 25-Apr-2003, the group acquired atlantech medizinische produkte vertriebs gmbh and on 28-Jan-2004, medical device alliance inc.
|
|
Name |
Title
|
Email
|
| Jack Giroux | Pres. - Arthrocare Sports Medicine | N/A | | Michael Gluk | CFO, Sr. VP | N/A | | Norman Sanders | VP - Corporate Development, Chief Medical Officer | N/A | | Jean Woloszko | VP, Chief Technical, Scientific Officer | N/A | | John Raffle | Sr. VP - Strategic Business Units | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 263,001 | 31,675 | | 2005 | 214,334 | 23,530 | | 2004 | 154,148 | (26,189)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
